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Tissue Doppler Image-Derived Measurements
During Isovolumic Contraction Predict
Exercise Capacity in Patients With Reduced
Left Ventricular Ejection Fraction
Eun Joo Cho, MD, PHD, Giuseppe Caracciolo, MD, Bijoy K. Khandheria, MD,
D. Eric Steidley, MD, Robert Scott, MD, Walter P. Abhayaratna, MD,
Krishnaswamy Chandrasekaran, MD, Partho P. Sengupta, MD, DM
Scottsdale, Arizona
O B J E C T I V E S We explored the incremental value of quantiﬁcation of tissue Doppler (TD) velocity
during the brief isovolumic contraction (IVC) phase of the cardiac cycle for the prediction of exercise
performance in patients referred for cardiopulmonary exercise testing (CPET).
B A C KG ROUND Experimental studies have shown that rapid left ventricular (LV) shape change
during IVC is essential for optimal onset of LV ejection. However, the incremental value of measuring IVC
velocities in clinical settings remains unclear.
METHOD S A total of 82 subjects (age 53  14 years, 56 men) were studied with echocardiography
and CPET. Reduced LV ejection fraction (EF) (EF 50%) was present in 38 (46%) subjects. Pulsed-wave
annular TD velocities were averaged from the LV lateral and septal annulus during isovolumic
contraction (IVCa), ejection, isovolumic relaxation, and early and late diastole (Aa) and compared with
peak oxygen consumption (VO2) and percentage of the predicted peak VO2 (% predicted peak VO2)
obtained from CPET.
R E S U L T S Patients with reduced EF had lower IVCa (6.3 vs. 4.5 cm/s, p  0.04), ejection (7.7 vs. 5.5
cm/s, p 0.001), and Aa velocities (7.9 vs. 6.6 cm/s, p 0.04). Similarly, % predicted peak VO2 was lower
in patients with reduced EF (52.9% vs. 73.1%, p  0.001) and correlated with the variations in IVCa (r 
0.7, p  0.001). Multivariate analysis of 2-dimensional and Doppler variables in the presence of reduced
LV EF revealed only IVCa and Aa as independent predictors of % predicted peak VO2 (r
2  0.612, p 
0.02 for IVCa and p 0.009 for Aa). The overall performance of IVCa in the prediction of exercise capacity
was good (area under the curve  0.86, p  0.001).
CONC L U S I O N S Assessment of TD-derived IVC and atrial stretch velocities provide independent
prediction of exercise capacity in patients with reduced LV EF. Assessment of LV pre-ejectional stretch
and shortening mechanics at rest may be useful for determining the myocardial functional reserve of
patients with reduced EF. (J Am Coll Cardiol Img 2010;3:1–9) © 2010 by the American College of
Cardiology Foundation
From the Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, Arizona. Dr. Khandheria is currently affiliated with
Aurora Cardiovascular Services, Aurora Sinai/St. Luke’s Medical Centers, Milwaukee, Wisconsin.Manuscript received May 7, 2009; revised manuscript received August 10, 2009, accepted August 11, 2009.
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2he isovolumic contraction (IVC) phase
of the cardiac cycle initiates interactions
between cardiac myofilaments through
energy-dependent calcium fluxes in the
yoplasm and sarcolemma (1,2). Approximately
0% of total myocardial oxygen consumption
VO2) is expended for a rapid rise in left ventric-
lar (LV) pressure during IVC (3). In vitro
xperiments using skinned muscle preparations
ave suggested that this energy-dependent early
hortening sequence may stretch activate the
ardiac muscle tissue for modulating the force
and duration of contraction (4 – 6).
Shortening mechanics during IVC thus
may be important for functionally adapt-
ing to physiological states with high
energy consumption and VO2 such as
exercise.
Transient reshaping of LV geometry
during IVC is registered on tissue
Doppler (TD) imaging as biphasic lon-
gitudinal myocardial velocity spikes (7).
The positive component of TD-derived
IVC velocity spikes has been shown to
correlate with the rate of change in LV
pressure (8). Furthermore, IVC velocity
spikes are associated with the energy
efficient sequence of LV intracavity
blood flow redirection through vortex
ring formation (9–12). In the present
study, we evaluated the incremental
value of TD-derived peak positive IVC
velocity as a noninvasive parameter for
the prediction of exercise efficiency in
patients referred for cardiopulmonary
exercise testing (CPET). We hypothe-
sized that TD-derived IVC velocity
would be independently related to peak
VO2 and predicted peak oxygen con-
sumption (% predicted peak VO2).
ETHODS
etween January 2007 and August 2008, 193
atients with complaints of dyspnea underwent
PET for objective assessment of exercise capac-
ty and a detailed transthoracic echocardiographic
xamination at Mayo Clinic Arizona. Patients
ith moderate or severe valve lesions (n  30,
5.5%), paced rhythm or ventricular assist device
n  38, 19.7%), atrial fibrillation (n  10, 5.1%)
nd significant lung disease (n  5, 2.6%), liver or
n
ty
n
r
ionenal failure (n  61, 31.6%), and congenital Ceart disease (n  25, 13.0%) were excluded from
he study. Based on left ventricular ejection
raction (LVEF), patients were classified into 2
roups: reduced LVEF (EF 50%; n  38, 46%)
nd normal LVEF (EF 50%; n  50, 54%).
chocardiography. Echocardiography and CPET
ere performed within 1 week (2.5  2.3 days).
ll patients were examined at rest in the left
ateral decubitus position. The echocardiographic
echniques and calculations of different cardiac
imension and volumes were performed accord-
ng to the recommendations of the American
ociety of Echocardiography (13). LVEF by
-dimensional echocardiography was obtained
y modified biplane Simpson’s method from
pical 4- and 2-chamber views. LV dimensions
nd wall thickness were made in parasternal
ong axis with M-mode cursor positioned just
eyond the mitral leaflet tips, perpendicular to
he long axis of the ventricle. LV diameter in
iastole and systole, LV mass, and fractional
hortening were measured. Left atrial volume was
alculated from areas measured in apical 2- and
-chamber views and indexed by body surface
rea. Left atrial total emptying fraction was
alculated by dividing differences between largest
nd smallest left atrial volume with largest left
trial volume.
itral ﬂow velocities. The mitral flow velocities
ere recorded with pulsed-wave Doppler with
he sample volume placed at the tip of the mitral
alve tips from the apical 4-chamber view. From
he mitral valve inflow velocity curve, peak
-wave velocity and its deceleration time, and
eak A-wave velocity were measured.
D imaging. Myocardial velocities were recorded
sing a standard pulse-wave Doppler technique
s previously described (14). High-frequency sig-
als in IVC velocities were filtered using a
yquist limit adjusted to a velocity range of 15
o 20 cm/s. Gains were minimized to allow for a
lear tissue signal with minimum background
oise as shown in Figure 1. Peak contraction and
elaxation velocities were averaged from the lat-
ral and septal corners of mitral valve annulus
uring IVC (IVCa), systolic ejection (Sa), and
arly (Ea) and late (Aa) diastolic phases of the
ardiac cycle at a speed of 100 mm/s (Fig. 1). We
lso measured isovolumic acceleration at the lat-
ral and medial mitral annulus as the slope of the
re-systolic velocity curve expressed in m/s2 (15).B B R E V I A T I O N S
N D A C R O N YM S
a annular tissue velocity
uring late diastolic period
PET cardiopulmonary
xercise test
a annular tissue velocity
uring early diastolic period
F ejection fraction
VC isovolumic contractio
hase
VCa annular tissue veloci
uring isovolumic contractio
eriod
V left ventricle/ventricula
VEF left ventricular eject
raction
ETmetabolic equivalent
OC receiver-operator
haracteristic
D tissue Doppler
CO2 carbon dioxide
roduction
Eminute ventilation
O2 oxygen consumption
predicted peak VO2 
redicted peak oxygenPET. All patients underwent a maximal exercise
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3tress test on an electrically braked stationary
ycle ergometer using ramp protocol (n  9,
1%) or treadmill test using modified ramp pro-
ocol (n  73, 89%). Previous studies have shown
he prognostic thresholds of peak VO2 and
inute ventilation/carbon dioxide production
VE/VCO2) slope in patients with heart failure
o be similar irrespective of mode of exercise (16).
atients were encouraged to exercise to exhaus-
ion. During the test, patients wore a tightly
tting facemask which was connected to a cap-
ograph and a sample tube enabling online ven-
ilation and metabolic gas exchange measure-
ent. Ventilatory expired gas analysis (as well as
pirometry) was performed using a metabolic cart
Medgraphics CPX ULTIMA Cardio 2, Minne-
polis, Minnesota). Exercise was started at a work
oad of 30 W, with further increment of 10 W
very minute. All patients were encouraged to
xercise to exhaustion, with a peak respiratory
xchange greater than 1.1. Peak VO2 was defined
s the highest O2 consumption during any stage
f maximal exercise that could be sustained for 1
in (or 30 s). Data are expressed as relative
alues and as percentages of the predicted VO2 as
ell. Metabolic equivalents was defined per con-
ention as equivalent to the consumption of 3.5
l of oxygen per kilogram of body mass per
inute (17). The VO2, VCO2, VE, respiration
ate, respiratory exchange ratios (VCO2/VO2),
Figure 1. Measurement of Annular Tissue Velocities
Peak contraction and relaxation velocities were averaged from the late
tion (IVCa), systolic ejection (Sa), isovolumic relaxation (IVRa), early (Ea),nd other standard respiratory parameters wereonitored continuously breath by breath and
veraged every 15 s. A 4-lead electrocardiogram
ecorded heart rate continuously.
nd septal corners of mitral valve annulus during isovolumic contrac-
late (Aa) diastolic phases of the cardiac cycle at a speed of 100 mm/s.
Table 1. Clinical Characteristics
LVEF <50%
(n  38)
LVEF >50%
(n  44)
Men (n) 27 (71.1%) 29 (65.9%)
Mean age (yrs) 52 13 53 14
LVEF (%) 26 10 66 8
Body mass index (kg/m2) 29.2 6.4 28.5 6.0
Left bundle branch block 10 (26.3%) 3 (6.8%)
Diabetes 12 (31.6%) 7 (15.0%)
Hypertension 12 (31.6%) 23 (52.3%)
Current medication
ACEI or ARB 26 (68.4%) 14 (31.8%)
Beta-blocker 25 (65.8%) 23 (52.3%)
Calcium-channel blocker 1 (2.6%) 6 (13.6%)
Digoxin 15 (39.5%) 3 (6.8%)
Diuretics 30 (78.9%) 18 (40.9%)
Nitrates 1 (2.6%) 1 (2.3%)
Etiology
Idiopathic 10 (26.3%) 8 (18.2%)
Ischemic 17 (44.7%) 5 (11.4%)
Hypertensive 4 (10.5%) 11 (25.0%)
Hypertrophic 1 (2.6%) 19 (43.2%)
Miscellaneous* 6 (15.9%) 1 (2.3%)
Values are n (%) or mean  SD. *Miscellaneous etiologies included drug-in
post-partum cardiomyopathy in 2 patients each and arrhythmogenic right ventricu
and inﬁltrative disease for 1 patient each for the subgroup with reduced ejection
tachycardiomyopathy in 1 patient for the subgroup with normal ejection fraction.
ACEI  angiotensin-converting enzyme inhibitor; ARB  angiotensin receptral ap Value
0.40
0.86
0.001
0.65
0.03
0.10
0.06
0.002
0.16
0.081
0.001
0.001
0.72
0.54
0.002
0.02
0.001
—
duced and
lar dysplasia
fraction and
or blocker;
LVEF  left ventricular ejection fraction.
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4tatistical analysis. All continuous data were re-
orted as mean  SD, and categorical data as
ercentage. To determine intraobserver variabil-
ty, 1 observer (G.C.) measured the myocardial
elocities in 25 randomly selected patients. In-
raobserver variability was calculated as the dif-
erence in 2 measurements of the same subject by
observer divided by the mean value. To evaluate
he interobserver variability, the myocardial ve-
ocities were obtained in 68 patients by 2 inde-
endent observers (E.C. and G.C.), each without
nowledge of the results obtained by the other.
nterobserver variability was calculated as the
ifference in 2 measurements of the same subjects
y 2 different observers divided by the mean
alue. Independent t test was used for compari-
ons of continuous variables between patients
ith normal and reduced EF. Pearson’s correla-
ion coefficient was used to reveal relations be-
ween 2 continuous variables. The receiver-
perator characteristic (ROC) curve was plotted
o determine the sensitivity and specificity to
redict exercise capacity, and Delong Delong
larke-Pearson method (Analyse-it software,
icrosoft Excel, Redmond, Washington) was
sed to compare diagnostic power of ROC curves
-Dimensional, M-Mode, and Doppler Echocardiographic Data
LVEF <50%
(n  38)
LVEF >50%
(n  44) p Value
26.3 9.7 66.0 7.7 0.001
10.1 3.0 14.7 6.7 0.001
) 10.0 2.5 12.2 3.8 0.003
) 56.1 11.8 29.2 8.4 0.001
) 64.8 10.7 46.7 7.7 0.001
147.3 87.0 44.0 29.4 0.001
) 198.2 88.9 102.4 40.0 0.001
dex (g/cm2) 144.9 54.1 126.5 53.4 0.13
all thickness* 0.3 0.1 0.6 0.2 0.001
volume (ml/m2) 40.5 14.6 39.7 17.8 0.83
ptying fraction (%) 49.7 23.2 58.5 16.8 0.12
(m/s) 0.83 0.26 0.84 0.37 0.90
(m/s) 0.58 0.27 0.68 0.28 0.14
14.6 6.6 13.4 7.8 0.50
1.73 1.08 1.34 0.62 0.07
n time (ms) 159 52 201 56 0.001
74 35 97 41 0.08
ricular systolic
(mm Hg)
45.3 17.9 34.9 13.2 0.12
tricular posterior wall thickness (LVPW)/left ventricular end-diastolic dimension
olumic relaxation time; IVS  interventricular septal thickness; LA  left atrial;
ft ventricular end-diastolic dimension; LV  left ventricular; LVESD  left
nd-systolic dimension; LVEDV  left ventricular end-diastolic volume; LVESV vlar end-systolic volume; 2D  2-dimensional; other abbreviations as in Table 1.18). Multiple stepwise regression analysis was
sed to evaluate the relationship between %
redicted peak VO2 and clinical and echocardio-
raphic variables. Variables that showed signifi-
ant correlations (p  0.1) with % predicted peak
O2 on simple regression analysis were selected.
tatistical analysis was performed with commer-
ially available software (SPSS 12.0 software,
PSS Inc., Chicago, Illinois). A p value 0.05
as considered statistically significant.
E SULTS
aseline clinical features of the patients and the
nderlying etiologies are shown in Table 1.
chocardiographic data. Patients with reduced
VEF had thinner interventricular septum (p 
.001) and posterior walls (p  0.003). However,
here were no significant differences in LV mass
ndex, indexed left atrial volume, and left atrial total
mptying fraction (Table 2). There were no signif-
cant differences in transmitral early and late inflow
elocities, E/Ea, and E/A (Table 2). However,
ardiac index was significantly reduced (p  0.003)
n patients with reduced EF.
ulse-wave TD data. The absolute intraobserver
ifferences for measuring TD velocities during
VC were 0.06  1.2 cm/s and the corresponding
ntraobserver variability were 1.2  2.4%. Annu-
ar velocities averaged from the septal and lateral
orners of mitral annulus were significantly re-
uced in patients with reduced EF during IVC
6.3 vs. 4.5 cm/s, p  0.04), ejection (7.7 vs. 5.5
m/s, p  0.001), and late diastolic (7.9 vs. 6.6
m/s, p  0.04) phases of the cardiac cycle (Table
). Similarly, isovolumic acceleration measured
uring the pre-ejection period and averaged from
he septal and the lateral corners of mitral annu-
us was significantly reduced in patients with
educed EF (1.37  0.53 m/s2 vs. 1.85  0.61
/s2, p  0.001).
PET. Maximum exercise duration (Table 4) was
ignificantly lower in patients with reduced
VEF (363  123 s vs. 443  102 s, p  0.006).
imilarly, exercise variables like MET at peak
O2 (p  0.001), peak VO2 at maximal exercise
p  0.001), and % predicted peak VO2 (p 
.001) were significantly lower, while VE/VCO2
p  0.04) and VE/VO2 (p  0.03) were signif-
cantly increased in patients with reduced LVEF.
orrelation between echocardiographic parameters
nd CPET. Correlations between TD velocity, iso-Table 2. 2
LVEF (%)
IVS (mm)
LVPW (mm
LVESD (mm
LVEDD (mm
LVESV (ml)
LVEDV (ml
LV mass in
Relative w
Indexed LA
LA total em
E velocity
A velocity
E/Ea
E/A
Deceleratio
IVRT (ms)
Right vent
pressure
*2  left ven
(LVDd).
IVRT  isov
LVEDD  le
ventricular eolumic acceleration and peak VO2, and % pre-
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5icted peak VO2 for the entire group and for
atients with reduced and preserved EF are
hown in Table 5. For patients with reduced EF,
f all the echocardiographic and clinical param-
ters assessed, annular velocities during the IVC
eriod and late diastolic period showed the best
orrelations (Fig. 2) and were independent pre-
ictors for % predicted peak VO2 (Table 6,
nline Table 1). The overall performance of
VCa, isovolumic acceleration, and Aa (Fig. 3) in
he prediction of exercise capacity was good (area
nder the curve 0.86, p  0.001 for IVCa; 0.74,
 0.02 for isovolumic acceleration; and 0.82,
 0.003 for Aa).
I SCUS S ION
he main findings of this study are: 1) TD-
erived IVCa and Aa velocities are significantly
ttenuated in patients with reduced LVEF;
nd 2) IVCa and Aa are the only 2 independent
Table 3. Tissue Doppler-Derived Longitudinal LV Annular
Dynamics
LVEF <50%
(n  38)
LVEF >50%
(n  44) p Value
Medial
IVCa (cm/s) 4.3 1.8 6.3 2.3 0.001
IVA (m/s2) 1.40 0.61 1.94 0.69 0.001
Sa (cm/s) 4.9 1.9 7.0 1.8 0.001
IVRa (cm/s) 4.2 1.8 4.0 2.1 0.585
Ea (cm/s) 5.0 2.3 7.1 2.9 0.001
Aa (cm/s) 5.8 2.9 7.6 2.8 0.008
Ea/Aa 1.1 0.7 1.1 1.0 0.967
Lateral
IVCa (cm/s) 4.8 2.9 5.4 2.6 0.392
IVA (m/s2) 1.34 0.56 1.75 0.71 0.007
Sa (cm/s) 6.1 3.7 8.4 3.3 0.006
IVRa (cm/s) 4.2 2.5 4.6 2.8 0.353
Ea (cm/s) 8.2 4.1 8.1 3.6 0.912
Aa (cm/s) 7.1 3.4 8.2 3.3 0.157
Ea/Aa 1.3 0.6 1.1 0.7 0.293
Average
IVCa (cm/s) 4.5 2.0 6.3 2.2 0.042
IVA (m/s2) 1.37 0.53 1.85 0.61 0.001
Sa (cm/s) 5.5 2.1 7.7 2.1 0.001
IVRa (cm/s) 4.1 1.6 4.3 2.2 0.611
Ea (cm/s) 6.6 2.9 7.6 3.1 0.160
Aa (cm/s) 6.6 2.9 7.9 2.8 0.044
Ea/Aa 1.2 0.5 1.1 0.6 0.783
Aa  annular late diastolic wave; Ea  annular early diastolic wave; IVA 
isovolumic acceleration; IVCa  annular isovolumic contraction wave; IVRa 
annular isovolumic relaxation wave; LV  left ventricular; LVEF  left
ventricular ejection fraction; Sa  annular ejection wave.chocardiographic predictors for exercise capacityn patients with reduced LVEF. To the best of
ur knowledge, this is the first study that has
valuated the relationship between isovolumic
ontraction velocities and exercise performance in
atients undergoing CPET.
chocardiographic predictors of exercise capacity in
eart failure patients. Conventional measures of
V function such as resting EF and Doppler
ndexes such as peak A velocity or E/A are
oad-dependent and poorly associated with symp-
oms and exercise capacity (19–24). Previous
tudies have correlated TD-derived parameters
ike early diastolic lengthening velocities (Ea) and
/Ea ratio with the extent of exercise limitation
n patients with reduced LVEF (25–28). Recent
nvestigations have further suggested the com-
ined use of systolic ejection and early diastolic
D parameter, rather than isolated measure-
ents, would be essential for proper character-
zation of the extent of exercise intolerance (29).
he duration of the total isovolumic period is a
ajor determinant of peak VO2 (30,31). More-
ver, TD-derived isovolumic indexes were previ-
usly suggested to be relatively load-independent
nd therefore more sensitive markers of myocar-
ial contractility than parameters measured dur-
ng ejection and diastolic filling phases (32,33).
he specific contribution of IVC period and the
elationship between IVC velocity and peak VO2,
owever, were previously unknown. Our investi-
ation suggests that IVC contraction and LV
Table 4. Cardiopulmonary Exercise Test
LVEF <50%
(n  38)
LVEF >50%
(n  44)
Exercise duration (s) 363 123 443 102
RER at Max VO2 1.2 0.1 1.5 0.6
Basal HR (beats/min) 81 18 76 21
Basal RR (per min) 18 3 18 5
Basal SBP (mm Hg) 114 16 126 19
Basal DBP (mm Hg) 69 11 76 13
Max HR (beats/min) 120 23 129 27
Max RR (per min) 34 7 31 7
Max SBP (mm Hg) 127 28 150 41
Max DBP (mm Hg) 73 12 82 17
MET at Max VO2 4.4 1.4 5.8 1.7
Peak VO2 (ml/kg/min) 15.4 5.0 20.0 6.3
% Predicted peak VO2 (%) 52.9 14.2 73.1 17.5
VE/VCO2 at Max VO2 38.4 8.9 33.9 8.3
VE/VO2 at Max VO2 45.2 8.7 39.3 9.5
DBP  diastolic blood pressure; HR  heart rate; LVEF  left ventricular ejecti
Max  maximal; MET  metabolic equivalents; RER  respiratory exchange
respiratory rate; SBP  systolic blood pressure; VCO2  carbon dioxide produp Value
0.006
0.183
0.192
0.836
0.004
0.019
0.139
0.098
0.025
0.022
0.001
0.001
0.001
0.041
0.030
on fraction;
ratio; RR 
ction; VE minute ventilation; VO2  oxygen consumption.
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6tretch velocities resulting from atrial contrac-
ion, rather than ejection or early diastolic phase
engthening velocities, provide superior predic-
ion of the exercise performance. In contrast to
VC velocity, IVC acceleration showed weaker
orrelation with % predicted peak VO2 (r  0.34,
 0.044) (Online Fig. 1). The diagnostic power
f IVC velocity and acceleration for predicting %
redicted peak VO2 50% were, however, simi-
ar (0.80 vs. 0.76, p  NS for the entire group
nd 0.86 vs. 0.74, p  0.06 for LVEF 50%).
During electromechanical coupling, influx of
a2 activates both energy-producing and
nergy-consuming processes, providing mecha-
isms for cardiac muscle to dramatically increase
ontraction without any change in energetic in-
ermediates (34). Early activated regions of the
V contract, stretching the late activated regions
Figure 2. Annular Velocities and % Predicted Peak VO2 >50%
Correlation between annular tissue Doppler velocity and % predicte
Table 5. Correlation Between Tissue Doppler Velocity and Exerc
Overall Group (n  82) LVEF
Peak VO2 % Predicted VO2 Peak VO2
r p Value r p Value r p V
IVCa 0.32 0.006 0.40 0.001 0.45 0.
IVA 0.17 0.14 0.29 0.01 0.08 0.
Sa 0.26 0.02 0.49 0.001 0.35 0.
IVRa 0.03 0.82 0.04 0.72 0.26 0.
Ea 0.20 0.08 0.14 0.22 0.32 0.
Aa 0.25 0.03 0.39 0.001 0.44 0.
Ea/Aa 0.21 0.07 0.14 0.21 0.27 0.
E/Ea 0.19 0.11 0.13 0.27 0.42 0.
Abbreviations as in Tables 3 and 4.systolic dysfunction. Abbreviations as in Figure 1.9). This sequence of early shortening and stretch
uring IVC provides an intrinsic servo-mechanism
or dynamically modulating the force of cardiac
uscle contraction and the timing of cross-over
nto diastole (4 –6). LV stretch due to atrial
ontraction precedes isovolumic contraction, and
oth may dynamically modulate the forces oper-
ting in the ejection and early diastolic phases of
he cardiac cycle. For example, in our study we
ound that IVC velocity correlated with ejection
hase velocities (Online Fig. 2). This relationship
etween the phases of the cardiac cycle may be a
otential reason why the diagnostic yield of TD
maging for predicting exercise capacity is im-
roved when Aa and IVCa velocities are incor-
orated. Witte et al. (35) stressed the role of
nnular tissue velocity in the late diastolic period
nd its correlation with peak VO2. Late diastolic
eak oxygen consumption (VO2) in patients with left ventricular
Capacity
0% (n  38) LVEF >50% (n  44)
% Predicted VO2 Peak VO2 % Predicted VO2
r p Value r p Value r p Value
0.69 0.001 0.15 0.35 0.08 0.62
0.33 0.05 0.08 0.64 0.04 0.80
0.51 0.002 0.03 0.88 0.17 0.28
0.45 0.009 0.19 0.23 0.20 0.22
0.42 0.01 0.05 0.74 0.15 0.34
0.71 0.001 0.01 0.97 0.05 0.76
0.35 0.04 0.18 0.25 0.05 0.74
0.54 0.001 0.04 0.80 0.14 0.38d pise
<5
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7tretch velocities reflect left atrial function and
he adaptive capacity of the left atrium to com-
ensate for increased diastolic volume and filling
ressure of the LV in heart failure patients
36–38). Moreover, the peak of Aa and the
ositive IVCa velocity spike transit on a contin-
um as seen on the TD-derived spectral velocity
aveforms. The correlation of IVCa and Aa with
predicted peak VO2 may thus reflect atrioven-
ricular events that operate on a continuum and
rime the LV for optimal systolic ejection and
iastolic suction.
rognostic value of CPET in heart failure patients. The
erm “VO2 max” refers to a plateau in peak oxygen
ptake in line with increasing workload during
xercise. However, congestive heart failure patients
re normally unable to exercise to such a level;
herefore, the term peak VO2 is used. Peak VO2 is
ffected by sex and age. In addition, because oxygen
ptake is relativized for body mass, heavier patients
ith a similar fitness level will have a lower peak
O2. Therefore, when considering an individual
atient, one must consider adjustments for age, sex,
nd body mass of the patient. Assessment of peak
O2 threshold can also be problematic in some
eart failure patients due to deconditioning, lack of
otivation, and difficulty exercising with a face-
ask/mouthpiece in situ. In 1996, Stelken et al.
39) suggested the use of the % predicted peak
O2 for identifying patients at risk for future
ardiac event. In their study, % predicted peak
O2 cut point 50% was sensitive in detecting
ore events than the use of absolute peak VO2
alue. Subsequently, Osada et al. (40) reported
hat for peak VO2 14 ml/kg, peak exercise
ystolic blood pressure and % predicted peak VO2
50%) in heart transplant recipients were the 2
ost important predictors for the combined end
oint of death or listing as status 1 transplanta-
ion priority. Interestingly, for our study the
omparison of TD and exercise parameters re-
ealed superior correlation coefficients between
D parameters and % predicted peak VO2 than
ith peak VO2. Furthermore, ROC analysis
howed TD parameters were able to predict %
redicted peak VO2 50%, whereas similar ob-
ervations were not seen for peak VO2. The role
f % predicted peak VO2 thus needs more careful
ssessment in future investigations.
tudy limitations. The present study only evaluated
he myocardial velocity using TD imaging in the
ongitudinal direction. Further studies would beequired for understanding the value of measur-
ng 2- and 3-dimensional strain deformation
sing Doppler and angle-independent techniques
uch as speckle tracking. Future studies would
lso need to compare the clinical value of mea-
uring LV torsional mechanics in predicting ex-
rcise capacity, particularly for the group of
atients with preserved EF in whom the longi-
udinal velocities were unable to predict exercise
apacity in our study.
ONCLUS IONS
ulsed-wave mitral annular isovolumic velocities
easured by TD imaging are useful clinical
Figure 3. Diagnostic Value of Tissue Doppler-Derived Measurem
The receiver-operator characteristic curve analysis of IVCa, Aa, an
eration (IVA) for prediction of % predicted peak volume of oxyge
with left ventricular systolic dysfunction. Area under the curve w
0.001 for IVCa; area under the curve was 0.82, p value was 0.003
under the curve was 0.74, p value was 0.026 for IVA. A cutoff va
IVCa had 88% sensitivity and 72% speciﬁcity, while a cutoff valu
had 81% sensitivity and 65% speciﬁcity, and 0.96 m/s for IVA ha
and 50% speciﬁcity for predicting % predicted volume of oxygen
Table 6. Multiple Regression Analysis for % Predicted VO2 in Pa
With LVEF <50%
Model
Unstandardized
Coefﬁcients
Standardized
Coefﬁcients
 SigBeta Standard Error Beta
Coefﬁcient 24.915 4.990 — 5.000 
Aa 250.743 88.243 0.464 2.842
IVCa 241.003 99.207 0.397 2.429
r2  0.612, % predicted VO2  24.915 250.743  Aa  241.003
Dependent variable: % predicted VO2, excluded variables are ejection fraction
fractional area change, annular ejection wave velocity, E/annular early dias
annular early diastolic wave velocity, annular early diastolic wave/Aa, annular
relaxation wave velocity, and E/A that showed p value 0.1 in simple regress
(shown in Online Table 1).
Abbreviations as in Tables 3 and 4.p
Value
ents
d isovolumic accel-
n 50% in patients
as 0.86, p value was
for Aa; and area
lue of 3.8 cm/s for
e of 5.8 cm/s for Aa
d 95% sensitivity
50%. Abbrevia-tients
niﬁcance
0.001
0.009
0.023
 IVCa
, left atrial
tolic wave,
isovolumic
ion analysistions as in Figure 1.
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8ariables for predicting cardiopulmonary exercise
apacity in patients with reduced LV systolic
unction. Peak stretch and shortening velocities
uring late diastolic and IVCs of cardiac cycle are
ignificantly attenuated in patients with reducedrhythms: new insights from use of high- Estrada-Quintero Tiographic predictors of the extent of exercise
imitation.
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